NCT03419676View on ClinicalTrials.gov

Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

February 10, 2022

Conditions
Pancreatic Fistula
Interventions
DEVICE

Hemopatch

Collagen patch derived from bovine dermis, coated with NHS-PEG, applied covering the pancreaticojejunostomy after pancreatoduodenectomy once the anastomosis is completed.

Trial Locations (1)

50008

Mario Serradilla Martín, Zaragoza

All Listed Sponsors
collaborator

Aragon Health Science Institute

OTHER_GOV

lead

Hospital Miguel Servet

OTHER

NCT03419676 - Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy | Biotech Hunter | Biotech Hunter